Latest Ventricular fibrillation Stories
Scientists have long believed that atrial fibrillation, the most common form of sustained heart arrhythmia, is an electrical problem of the heart. However, a new study has uncovered a surprising genetic cause for the rare and particularly severe form of heart disease.A team of researchers at the Cleveland Clinic has found that defects in a gene known as NUP155, a key component of the nuclear pore complex that is involved in shuttling molecules in and out of the cell nucleus, also leads to...
NEW ORLEANS, Nov. 7 /PRNewswire/ -- Royal Philips Electronics today announced that Dr. Ohad Ziv, Clinical Cardiac Electrophysiologist at Rhode Island Hospital, has been selected as the recipient of the second annual American Heart Association-Philips Resuscitation Fellowship Award.
By Walker, Dennis D Johnson, Monica L; Craig-Gray, Robert W; Loyd, Frank ABSTRACT Introduction: Brugada syndrome describes a subgroup of patients at risk for polymorphic ventricular tachycardia, ventricular fibrillation, and sudden cardiac death and is likely underdiagnosed among aviators.
Researchers in Spain have reported a possible link between the deaths of young men and incarceration.
By Freeman, Kimberly Hendey, Gregory W; Shalit, Marc; Stroh, Geoff ABSTRACT Study Objective. To compare the outcomes of out-of hospital cardiac arrest (OHCA) victims treated with monophasic truncated exponential (MTE) versus biphasic truncated exponential (BTE) defibrillation in an urban EMS system.
St. Jude Medical, Inc. (NYSE:STJ) today announced regulatory approval, in addition to reimbursement approval, from the Japanese Ministry of Health, Labour and Welfare (MHLW), for the Durata(TM) defibrillation lead, the company's next-generation high-voltage lead.
SCHAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched amiodarone HCl injection, USP, a class III antiarrhythmic indicated for the treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia -- a potentially life-threatening irregular heart beat.
Harbinger Medical Inc.(TM) of Minneapolis, Minnesota USA today announced the results of a study presented at the 2008 Cardiostim meeting in Nice. Four abstracts, including two poster workshops by the study's primary investigator Dr.
Vicor Technologies, Inc. (OTCBB: VCRT), reviewed strategies and developments to (i) commercialize its patented device, the PD2i Cardiac Analyzer, for risk stratification of patients for Sudden Cardiac Death (SCD); (ii) its collaboration with the U.S.
Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits. But this convenience may come with unanticipated risks. A team of researchers from three leading universities has demonstrated that patientsâ€™ private medical information could be extracted and their devices reprogrammed without the patientsâ€™ authorization or knowledge.
The precordial thump is an application of mechanical energy through a calculated strike to the torso when in a specific fatal heart rhythm. This procedure is used in very specific circumstances by highly trained health professionals with ACLS certifications. The Procedure While in the presence of a patient that is suffering a potentially fatal heart rhythm, a medical provider can strike a calculated point on the sternum to disrupt that rhythm. The energy transferred by the provider is...
- A volcanic mudflow.